CHLORHYDRATE DE METOCLOPRAMIDE RENAUDIN 10 mg/2 ml, solution for injection in an ampoule 10 ampoules of 2 ml
Active ingredients: Metoclopramide hydrochloride, Metoclopramide hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection10 ampoules of 2 mlintramusculaire;intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CHLORHYDRATE DE METOCLOPRAMIDE RENAUDIN 10 mg/2 mL, solution injectable en ampoule
- Pharmaceutical form
- solution injectable
- Route of administration
- intramusculaire;intraveineuse
- Presentation description
- 10 ampoule(s) en verre de 2 ml
- Marketing authorisation holder
- LABORATOIRE RENAUDIN
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 12 Mar 2015
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63670380CIP72794688CIP133400927946882Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE MÉTOCLOPRAMIDEsolution | 10,50 mg · une ampoule de 2 ml | SA |
| CHLORHYDRATE DE MÉTOCLOPRAMIDE ANHYDREsolution | 10 mg · une ampoule de 2 ml | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.